Information Library
Results for: Brochures - Regulatory & Quality
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Turkey Oncology Capabilities
February 6, 2012
Turkey has outstanding access to patients with a population of almost 75 million. Quintiles recent experience demonstrates Turkey provides rapid patient enrollment with high patient retention rates and remains an emerging market with few competing studies – becoming a major hub for patient recruitment. -
Middle East Oncology capabilities
February 6, 2012
Outstanding access to patients in the Middle East region with a population of over 200 million means this is an important emerging region for the biopharmaceutical industry and Quintiles has a proven track record of rapid patient enrollment with high patient retention rates. -
Sustainable Compliance Begins with a Strong Foundation
December 8, 2011
The urgency of a problem often entices people to quickly focus on finding a solution and repairing the problem in order to immediately remedy the situation. -
Population PK/PD - Modeling and Simulation Optimization Tools
February 11, 2011
Population pharmacokinetic/ pharmacodynamic (PK/PD) modeling and simulation, available from Quintiles, is now endorsed by the FDA as often being instrumental in drug approval and labeling. -
Consulting – Breakthrough Thinking Built on Experience
November 23, 2010
Consulting at Quintiles brings a critical element to engagements: fresh thinking built on a full lifecycle understanding of biopharma realities today. -
Marketplace Success
October 22, 2010
The real value of working with the consulting group at Quintiles is that we help you chart the best path to marketplace success. -
Responding to FDA Enforcement
October 5, 2010
As the FDA ratchets up its enforcement actions, pharmaceutical and medical device companies are turning to Quintiles. Learn what differentiates our consulting solutions. -
Reinventing Safety
September 22, 2010
When you integrate all your safety information, you can make better decisions, navigate regulatory hurdles and get to market faster. -
Safety Strategy & Optimization
September 14, 2010
Learn how to enable your safety group to become a value-added contributor throughout the product lifecycle. -
Sub-Saharan Africa Phase II/III Fact Sheet
July 29, 2009
Sub-Saharan Africa fact sheet about Phase II/III trials. The gateway to Africa: Access to expanded clinical resources and patient populations in South Africa and beyond.
Page 1 of 1 (10 results)
